Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.26	139.48	68.54	23.7	13.81	338.55
Short-Term Investments	293.7	294.61	193.27	180.72	273.44	-
Cash & Short-Term Investments	328.96	434.09	261.81	204.42	287.25	338.55
Cash Growth	53.17%	65.80%	28.07%	-28.84%	-15.15%	497766.18%
Other Receivables	2.97	2.12	0.67	0.32	0.13	-
Receivables	2.97	2.12	0.67	0.32	0.13	-
Prepaid Expenses	1.82	1.9	2.35	2.64	2.97	3.01
Other Current Assets	0.58	0.37	1.68	1.52	0.33	0.58
Total Current Assets	334.33	438.47	266.51	208.9	290.69	342.14
Property, Plant & Equipment	1.91	2.06	3.26	2.5	4.72	0.08
Long-Term Deferred Charges	1.02	0.68	-	-	-	-
Other Long-Term Assets	15.2	9.76	7.17	4.25	0.54	0.51
Total Assets	352.45	450.98	276.95	215.65	295.95	342.72
Accounts Payable	3.47	4.46	2.7	0.37	0.02	0.72
Accrued Expenses	37.01	36.09	17.86	15.09	7.81	3.43
Current Portion of Leases	1.17	1.17	0.99	1.02	0.93	-
Current Income Taxes Payable	-	0.04	0.07	0.07	0.09	0.2
Other Current Liabilities	-	-	-	-	0.17	0.24
Total Current Liabilities	41.66	41.76	21.62	16.55	9.02	4.59
Long-Term Leases	0.31	0.26	1.43	1.55	2.36	-
Total Liabilities	44.97	42.02	23.05	18.1	11.38	4.59
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	858.45	843.92	559.18	408.33	388.9	371.23
Retained Earnings	-551.5	-435.11	-305.63	-208.98	-104.19	-33.09
Comprehensive Income & Other	0.53	0.14	0.35	-1.81	-0.15	-
Total Common Equity	307.49	408.96	253.9	197.55	284.57	338.14
Shareholders' Equity	307.49	408.96	253.9	197.55	284.57	338.14
Total Liabilities & Equity	352.45	450.98	276.95	215.65	295.95	342.72
Total Debt	4.48	1.43	2.42	2.57	3.29	-
Net Cash (Debt)	324.48	432.66	259.39	201.86	283.96	338.55
Net Cash Growth	52.29%	66.80%	28.50%	-28.91%	-16.12%	497766.18%
Net Cash Per Share	3.91	7.37	5.73	5.05	7.18	48.22
Filing Date Shares Outstanding	68.66	68.33	55.91	40.63	39.85	39.43
Total Common Shares Outstanding	68.65	74.31	54.99	40.29	39.84	39.43
Working Capital	292.67	396.72	244.89	192.35	281.67	337.55
Book Value Per Share	4.48	5.50	4.62	4.90	7.14	8.57
Tangible Book Value	307.49	408.96	253.9	197.55	284.57	338.14
Tangible Book Value Per Share	4.48	5.50	4.62	4.90	7.14	8.57
Machinery	-	-	-	-	1.7	0.14

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q